SCHEMBL7671623

SCHEMBL7671623

COc1cccc2c1[C@H]1CC[C@]3(C)[C@@H](C(C)=O)CC[C@H]3[C@@H]1CC2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.50
SERPINA6 P08185 2/20 0.48
CYP3A4 P08684 7/20 0.48
LMNA P02545 6/20 0.48
MAPK1 P28482 3/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
ALOX15 P16050 1/20 0.48
BRCA1 P38398 1/20 0.48
RECQL P46063 1/20 0.48
ESR2 Q92731 1/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
MAPT P10636 4/20 0.46
TSHR P16473 3/20 0.46
CYP2C9 P11712 2/20 0.46
HIF1A Q16665 2/20 0.46
ALDH1A1 P00352 2/20 0.46
PGR P06401 2/20 0.46
ADORA3 P0DMS8 2/20 0.46
AR P10275 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8998250 0.84 HSD17B10 (0.62) ESR1SERPINA6CYP3A4LMNAMAPK1
SCHEMBL10715584 0.82 HSD17B10 (0.46) ESR1SERPINA6CYP3A4LMNAMEN1
SCHEMBL7063532 0.80 ESR1 (0.53) ESR1SERPINA6CYP3A4LMNAMAPK1
SCHEMBL2169796 0.79 ESR1 (0.74) ESR1CYP3A4LMNAMAPK1MEN1
SCHEMBL13902797 0.79 ESR1 (0.74) ESR1CYP3A4LMNAMAPK1MEN1
SCHEMBL12473454 0.79 ESR1 (0.74) ESR1CYP3A4LMNAMAPK1MEN1
SCHEMBL8432942 0.76 LMNA (0.71) ESR1SERPINA6CYP3A4LMNAMAPK1
SCHEMBL12793146 0.76 LMNA (0.71) ESR1SERPINA6CYP3A4LMNAMAPK1
SCHEMBL3139258 0.76 LMNA (0.71) ESR1SERPINA6CYP3A4LMNAMAPK1
SCHEMBL2712861 0.75 SHBG (0.55) SHBG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1265911-A2 17-ALPHA-SUBSTITUTED-11-BETA-SUBSTITUTED-4-ARYL AND 21-SUBSTITUTED 19-NORPREGNADIENEDIONE AS ANTIPROGESTATIONAL AGENTS THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2002-12-18 EP disclosed
WO-2001074840-A2 17-ALPHA-SUBSTITUTED-11-BETA-SUBSTITUTED-4-ARYL AND 21-SUBSTITUTED 19-NORPREGNA 21-SUBSTITUTED 19-NORPREGNADIENEDIONE AS ANTIPROGESTATIONAL AGENTS THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF HEALTH AND HUMAN SERVICES (US) 2001-10-11 WO disclosed